Vir Biotechnology, Inc. VIR Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s operating income?
- Vir Biotechnology, Inc. (VIR) reported operating income of -$132.29M in Q1 2026.
- How has Vir Biotechnology, Inc.'s operating income changed year-over-year?
- Vir Biotechnology, Inc.'s operating income increased by 5.2% year-over-year, from -$139.55M to -$132.29M.
- What is the long-term trend for Vir Biotechnology, Inc.'s operating income?
- Over 3 years (2021 to 2025), Vir Biotechnology, Inc.'s operating income has grown at a 4.4% compound annual growth rate (CAGR), from $420.75M to -$479.33M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.